SeaStar Medical Holding Statistics
Total Valuation
ICU has a market cap or net worth of $26.39 million. The enterprise value is $35.29 million.
| Market Cap | 26.39M |
| Enterprise Value | 35.29M |
Important Dates
The last earnings date was Tuesday, April 16, 2024, after market close.
| Earnings Date | Apr 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ICU has 65.15 million shares outstanding. The number of shares has increased by 163.91% in one year.
| Shares Outstanding | 65.15M |
| Shares Change (YoY) | +163.91% |
| Shares Change (QoQ) | +8.09% |
| Owned by Insiders (%) | 15.41% |
| Owned by Institutions (%) | 1.24% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 24.88 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18
| Current Ratio | 0.18 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -914.00% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.91M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.99% in the last 52 weeks. The beta is -1.15, so ICU's price volatility has been lower than the market average.
| Beta (1Y) | -1.15 |
| 52-Week Price Change | -80.99% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 0.58 |
| Relative Strength Index (RSI) | 29.70 |
| Average Volume (30 Days) | 5,931,551 |
Short Selling Information
The latest short interest is 3.59 million, so 5.51% of the outstanding shares have been sold short.
| Short Interest | 3.59M |
| Short Previous Month | 3.24M |
| Short % of Shares Out | 5.51% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.21M |
| Pretax Income | -26.23M |
| Net Income | -26.23M |
| EBITDA | -25.15M |
| EBIT | -25.15M |
| Earnings Per Share (EPS) | -$1.21 |
Balance Sheet
The company has $176,000 in cash and $9.08 million in debt, giving a net cash position of -$8.91 million or -$0.14 per share.
| Cash & Cash Equivalents | 176,000 |
| Total Debt | 9.08M |
| Net Cash | -8.91M |
| Net Cash Per Share | -$0.14 |
| Equity / Book Value | -13.87M |
| Book Value Per Share | -0.21 |
| Working Capital | -10.74M |
Cash Flow
| Operating Cash Flow | -10.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.29M |
| FCF Per Share | -$0.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -163.91% |
| Shareholder Yield | -163.91% |
| Earnings Yield | -99.42% |
| FCF Yield | -38.98% |
Analyst Forecast
The average price target for ICU is $5.00, which is 1,134.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 1,134.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |